resources

News, annual reports, and a glance at our projects

featured resource

Pharma news important to global health

Through a strategic newsletter campaign and intelligence archive, Linksbridge Pharma builds consensus among diverse global health counterparts seeking to develop and deliver drugs, vaccines, and health products for vulnerable populations everywhere.

case studies

Foundations of Market Shaping

Drawing on the expertise of over 30 market shaping actors and our own team of seasoned global health professionals, Linksbridge created a resource that offers foundational market shaping concepts, best practices, definitions, and practical guidance for intervention planning and execution.

Global Vaccine Market Model (GVMM)

In collaboration with key global health actors, Linksbridge developed and maintains a best-in-class intelligence resource delivering a comprehensive market overview for over 20 global health vaccines.

CEPI vaccine impact assessments

To prioritize vaccine investments, our partners at CEPI needed to understand the regional and global impact of new vaccines under varying scenarios—including hypothetical pandemics triggered by a viral variant.

Switching to 5-dose vials

Linksbridge developed a technical assistance strategy and a portfolio of resources to aid countries in switching to 5-dose vials of measles-containing vaccine, an easy-to-implement measure for boosting coverage while reducing wastage and lowering costs.

COVAX Covid-19 vaccine allocation algorithm

On behalf of the COVAX Joint Allocation Taskforce, Linksbridge data scientists developed an algorithm responsible for allocating approximately 900 million Covid-19 vaccine doses in 2021.

projects

Wolbachia Market Analysis

In collaboration with the Gates Foundation and other stakeholders, Linksbridge created materials in support of the market entry and scale-up of a novel technology for controlling mosquitoes and vector-borne diseases.

Health Campaigns Intelligence Hub

This cross-cutting resource captures worldwide data on health campaign activities, giving stakeholders from the country to the global level improved visibility and new opportunities for more efficient and better-integrated campaigns.

MCV 5-dose assessment support tool

The MCV 5-dose assessment support tool helps countries evaluate the programmatic, financial, and logistical trade-offs of switching from MCV 10-dose to 5-dose vials.

Health Campaigns news roundup

A monthly newsletter covering supplementary immunization activities and other health campaigns.

Access tools and resources created as global public goods under the Gates Foundation-funded Market Ecosystem Thought Leadership (META) initiative via the META Hub. Reach out to ghms@linksbridge.com with questions related to Hub access.

ANNUAL reports

2024 Impact Report

A reflection on our 2024 milestones and the challenges looming in 2025.

2023 Transparency Report

Learn more about our employee-owned social purpose corporation as we celebrate 15 years.

2022 Transparency Report

As Linksbridge prepared to transition to employee ownership, the team advanced MCV 5-dose work (in collaboration with Gavi, WHO, and UNICEF) and published a review of our COVAX allocation algorithm in the Oxford Review of Economic Policy.

2021 Transparency Report

We expanded our impact in 2021 with the launch of the Linksbridge Foundation, awarding our first no-strings-attached gifts to Outright International ($25,000), Legal Counsel for Youth and Children ($25,000), and other grantees.